Literature DB >> 33910764

Therapeutic application of Sertoli cells for treatment of various diseases.

Rachel L Washburn1, Taylor Hibler1, Lea Ann Thompson1, Gurvinder Kaur2, Jannette M Dufour3.   

Abstract

Sertoli cells (SCs) are immune privileged cells found in the testis that function to immunologically protect maturing germ cells from immune destruction. This immune protection is due to the blood-testis-barrier, which prevents infiltration of cytotoxic immune cells and antibodies, and SC production of immunomodulatory factors, that favor a tolerogenic environment. The ability of SCs to create an immune privileged environment has led to the exploration of their potential use in the treatment of various diseases. SCs have been utilized to create a tolerogenic ectopic microenvironment, to protect co-grafted cells, and to deliver therapeutic proteins through gene therapy. To date, numerous studies have reported the potential use of SCs for the treatment of diabetes, neurodegenerative disorders, and restoration of spermatogenesis. Additionally, SCs have been investigated as a delivery vehicle for therapeutic products to treat other diseases like Laron syndrome, muscular dystrophy, and infections. This review will provide an overview of these therapeutic applications.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell therapy; Immune privilege; Sertoli cell; Testis; Transplantation

Mesh:

Year:  2021        PMID: 33910764     DOI: 10.1016/j.semcdb.2021.04.007

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  4 in total

1.  Report and Abstracts of the 18th Meeting of the Interuniversity Institute of Myology: Virtual meeting, October 21-24, 2021.

Authors:  Francesca Grassi; Sestina Falcone
Journal:  Eur J Transl Myol       Date:  2021-11-29

Review 2.  Sertoli Cell Immune Regulation: A Double-Edged Sword.

Authors:  Rachel L Washburn; Taylor Hibler; Gurvinder Kaur; Jannette M Dufour
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

3.  Sertoli Cells Improve Myogenic Differentiation, Reduce Fibrogenic Markers, and Induce Utrophin Expression in Human DMD Myoblasts.

Authors:  Laura Salvadori; Sara Chiappalupi; Iva Arato; Francesca Mancuso; Mario Calvitti; Maria Cristina Marchetti; Francesca Riuzzi; Riccardo Calafiore; Giovanni Luca; Guglielmo Sorci
Journal:  Biomolecules       Date:  2021-10-12

4.  Melatonin modulates Nrf2 activity to protect porcine pre-pubertal Sertoli cells from the abnormal H2 O2 generation and reductive stress effects of cadmium.

Authors:  Desirée Bartolini; Iva Arato; Francesca Mancuso; Daniela Giustarini; Catia Bellucci; Carmine Vacca; Maria Chiara Aglietti; Anna Maria Stabile; Ranieri Rossi; Gabriele Cruciani; Mario Rende; Riccardo Calafiore; Giovanni Luca; Francesco Galli
Journal:  J Pineal Res       Date:  2022-05-24       Impact factor: 12.081

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.